Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial.
Cancers (Basel)
; 10(10)2018 Oct 17.
Article
en En
| MEDLINE
| ID: mdl-30336605
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Cancers (Basel)
Año:
2018
Tipo del documento:
Article